Cold Plasma Sterilization: Chemical-Free Low-Temperature Decontamination

Cold plasma (ionized gas at near-room temperature) is an emerging sterilization method that kills pathogens without heat or harsh chemicals. This article explains cold plasma’s science (a mix of reactive oxygen and nitrogen species, UV photons, and ions), and compares it to conventional methods. Applications span from disinfecting medical tools and PPE (especially relevant during the COVID era) to food and pharma packaging. Studies show cold plasma can inactivate bacteria and viruses in seconds (e.g. ~99% Salmonella reduction in 15s, significant virus kill in 1–2 minutes). We also discuss safety and regulatory aspects: cold plasma leaves no toxic residues, but operators must manage by-products like ozone. As of now, cold plasma devices are under research or limited use; regulatory bodies like FDA are evaluating their efficacy and safety. The technique’s advantages (speed, material compatibility) and challenges (equipment cost, scale-up) are reviewed.

What is Cold Plasma?

“Cold plasma," or “non-thermal plasma," is created by applying energy (electric field, RF, or microwave) to a gas (e.g., air, helium). Unlike the hot plasma in stars, cold plasma is near ambient temperature. It contains a “cocktail” of reactive agents: electrons, ions, UV photons, and especially reactive oxygen and nitrogen species (ROS/RNS) such as ozone (O₃), atomic oxygen (O), hydroxyl radicals (OH), nitric oxide (NO), hydrogen peroxide vapor, etc. These species are highly oxidative. A key point: cold plasma disinfects by chemical attack, not by heat. This means it can treat heat-sensitive materials (plastics, tissues) without damage.

Sterilization Mechanisms

Cold plasma deactivates microorganisms through multiple actions:

• Oxidative attack: ROS/RNS break down cell walls, membranes, and viral envelopes. For example, ozone and radicals strip electrons from lipids and proteins.
• DNA/RNA damage: UV photons and reactive species induce DNA strand breaks and base modifications, preventing replication.
• Electrostatic effects: Charged particles can physically puncture cell membranes.

Research confirms broad-spectrum kill. In lab tests, CAP inactivated bacteria (including biofilms) and viruses within seconds.

Applications of Cold Plasma

• Medical Sterilization: CAP can disinfect surgical tools, endoscopes, and PPE. It has been tested for quick decontamination of respirators and masks during shortages. Because it’s low-temperature, delicate medical materials (plastics, optics) are not damaged. CAP-based sterilizers could replace ethylene oxide (ETO) in the future, since no toxic gas is left behind. A prototype by FDA showed promise in inactivating SARS-CoV-2 on mask material using a CAP system.
• Wound and Skin Therapy: Some devices use cold plasma jets directly on wounds to kill bacteria (even antibiotic-resistant strains) and promote healing. Here plasma’s reactive species also modulate blood flow and growth factors. (These are typically regulated as medical devices.)
• Food and Packaging: Cold plasma can decontaminate food surfaces (fruits, spices) and processing equipment. It’s “waterless, zero-contact” and leaves no residues. For example, conveyors or packaging can be swept through a plasma field to kill pathogens. Because there is no heat, food quality is preserved. However, as a novel food processing method, regulatory agencies treat it cautiously (EFSA would evaluate any chemical changes in treated food).
• Pharmaceutical and Lab: CAP can sterilize ampoules, petri dishes, or pharmaceutical tools without chemicals. It’s being explored for sterilizing heat-sensitive biologics.

Effectiveness and Evidence

Cold plasma effectiveness is supported by studies:

• Bacteria: Pseudomonas, Salmonella, E. coli biofilms are greatly reduced by short CAP exposures.
• Spores and Viruses: More resistant spores (e.g. Bacillus) and non-enveloped viruses require longer treatments, but inactivation has been demonstrated in controlled tests.
• Viruses: FDA experiments showed CAP reduced virus infectivity; influenza H1N1 and SARS-CoV-2 were significantly inactivated after ~1–2 minutes of exposure.
• Material Compatibility: Cold plasma is gentler than autoclaving. Studies report no damage to most metals and plastics under typical CAP doses.

Advantages include very fast cycle times (seconds/minutes) compared to hours for ETO/steam, and no chemical residues. The reactive agents quickly revert to normal air (e.g. ozone decays) once plasma is off.

Safety and Regulatory Status

Cold plasma is largely chemical-free, so treated objects have no toxic residue. However:

• Ozone/UV Concerns: Cold plasma produces ozone and UV light. In open air, ozone can irritate lungs, so systems need ventilation or containment. Operators must follow OSHA limits on ozone exposure. UV output is typically low-energy, but direct eye/skin exposure should be avoided.
• Material Safety: Most materials tolerate CAP well, but long exposures can cause rubber hardening or polymer oxidation. Thus sterilization protocols specify times/energies.
• Regulation: CAP sterilizers are mostly in experimental or niche use. The U.S. FDA and EU regulators have not yet approved any mainstream CAP sterilizer product (as of 2026). FDA researchers are actively studying CAP for PPE decontamination. If CAP devices are marketed for sterilization, they must meet medical device or equipment standards (CE marking in EU or FDA clearance).
• Food Industry: EFSA (EU’s food safety authority) would require CAP-treated foods to pass safety evaluations (similar to novel processing approvals). Some companies treat surfaces (not the food itself) to simplify regulation.

Overall, cold plasma is seen as an eco-friendly alternative to chemical disinfectants, aligning with green technology trends. Continued R&D and pilot programs are bringing it closer to practical deployment in hospitals and industry.

Key Takeaways:

• Multi-action kill: Cold plasma (CAP) uses reactive O/N species and UV to destroy microbes without heat.
• Rapid and Dry: It can decontaminate surfaces (biofilms, equipment) in seconds, with no water or liquid chemicals.
• Low-Temperature: Safe for heat-sensitive materials (plastics, electronics, PPE fabrics).
• Emerging tech: Still under evaluation; regulatory approvals are pending as agencies study its safety and efficacy.

• Installation caution: Ensure proper shielding/ventilation to handle ozone/UV byproducts

  .